Abstract
A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zeskind PS, Stephen LE . Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113: 368–375.
Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293: 2372–2383.
Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL . Birth outcomes in pregnancy women taking fluoxetine. N Engl J Med 1996; 335: 1010–1015.
Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354: 579–587.
Stiskal JA, Kulin N, Koren G, Ho T, Ito S . Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001; 84: F134–F135.
Hendrick V, Stowe Z, Altshuler L, Hwang S, Lee E, Haynes D . Placental passage of antidepressant medication. Am J Psychiatry 2003; 160: 993–996.
American Academy of Pediatrics, Committee on Drugs. Transfer of drugs and other chemical into human milk. Pediatrics 2001; 108: 776–789.
Spencer MJ . Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1993; 92: 721–722.
Price JS, Waller PC, Wood SM, MacKay AV . A comparison of the post-marketing safety of the four selective serotonin reuptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42: 757–763.
Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G . Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005; 193: 2004–2009.
Muguruma K, Gray PW, Tjoelker LW, Johnston JM . The central role of PAF in necrotizing enterocolitis development. Adv Exp Med Biol 1997; 407: 379–382.
Nair GV, Gubel PA, O'Connor CM, Gattis WA, Murugesan SR, Serebruany VL . Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol 1999; 84: 321–323.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Potts, A., Young, K., Carter, B. et al. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. J Perinatol 27, 120–122 (2007). https://doi.org/10.1038/sj.jp.7211640
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211640
Keywords
This article is cited by
-
Depression During Pregnancy and Postpartum
Current Psychiatry Reports (2016)